DMAQ

Deep Medicine Acquisition Corp. [DMAQ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

DMAQ Stock Summary

In the News

DMAQ Financial details

Company Rating
-
Market Cap
12.9M
Income
-1.55M
Revenue
90K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-84.01
Forward P/E
-
PEG
-0.78
P/S
567.02
P/B
-57.66
P/C
-
P/FCF
-51.2
Quick Ratio
2.02
Current Ratio
2.02
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.48
EPS next Y
-
EPS next Q
-
EPS this Y
314.63%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
34.09%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-9%
ROE
-34%
ROC
-0.21%
Gross Margin
33%
Oper. Margin
-829%
Profit Margin
-680%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.96-19.91
52W High
-
52W Low
-
RSI
-
Rel Volume
5.2
Avg Volume
14.21K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.017
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
TL0.DE
LLY.SW
ABEA.DE
3V64.DE
META
Same Sector
FFH.TO
PAYG.L
EMAD.L
BTNB
WKBN.SW
Check Those
MCX.NS
6868.HK
000993.SZ
002468.SZ
SPC.L
Similar Market Cap
ALUVI.PA
SXTC
GVP
COUR.PA
MCC.BR

Company Profile

Financial Services Shell Companies
  • Volume Average 14.21K
  • Market Capitalization 12.9M
  • Employee 2
  • CEO Mr. Humphrey P. Polanen
  • Headquarters New York,NY,US
  • IPO Date 2021-12-02

Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.